We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+1.54%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$8.84B
AUM Growth
+$1.62B
Cap. Flow
+$1.69B
Cap. Flow %
19.13%
Top 10 Hldgs %
18.41%
Holding
656
New
169
Increased
202
Reduced
101
Closed
175

Top Buys

Rank Stock Value
1
RITM icon
Rithm Capital
RITM
+$78.4M
2
INFY icon
Infosys
INFY
+$65M
3
FFIV icon
F5
FFIV
+$64.6M
4
WDC icon
Western Digital
WDC
+$62.1M
5
CI icon
Cigna
CI
+$60.1M

Top Sells

Rank Stock Value
1
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$69.1M
2
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
+$68.2M
3
PCYC
PHARMACYCLICS INC
PCYC
+$57.6M
4
MDT icon
Medtronic
MDT
+$51.8M
5
DRC
DRESSER-RAND GROUP INC
DRC
+$50.2M

Sector Composition

Rank Sector Weight
1 Industrials 14.28%
2 Healthcare 13.44%
3 Technology 12.36%
4 Financials 10.47%
5 Energy 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INNL
301
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$3.52M 0.04%
240,959
+73,044
+44% +$810K
S
302
CALL
DELISTED
Sprint Corporation
S
$3.37M 0.04%
+740,000
New +$3.56M
CSTM icon
303
Constellium
CSTM
$3.99B
$3.35M 0.04%
282,964
+22,030
+8% +$346K
TAST
304
DELISTED
Carrols Restaurant Group, Inc.
TAST
$3.31M 0.04%
318,543
-185,447
-37% -$1.79M
META icon
305
PUT
Meta Platforms (Facebook)
META
$1.51T
$3.22M 0.04%
37,500
-212,500
-85% -$17.4M
ACSF
306
DELISTED
American Capital Senior Floating, Ltd.
ACSF
$3.17M 0.04%
250,888
-42,765
-15% -$564K
GNMK
307
DELISTED
GenMark Diagnostics, Inc
GNMK
$3.16M 0.04%
349,153
+101,566
+41% +$1.02M
ARMK icon
308
Aramark
ARMK
$14.7B
$3.1M 0.04%
138,500
-41,979
-23% -$948K
JPM icon
309
JPMorgan Chase
JPM
$950B
$3.06M 0.03%
+45,164
New +$2.95M
AMPH icon
310
Amphastar Pharmaceuticals
AMPH
$916M
$3.04M 0.03%
173,062
+12,656
+8% +$197K
BIIB icon
311
Biogen
BIIB
$30.7B
$3.03M 0.03%
+7,500
New +$3.01M
BIIB icon
312
PUT
Biogen
BIIB
$30.7B
$3.03M 0.03%
7,500
-75,000
-91% -$30.1M
MWV
313
DELISTED
MEADWESTVACO CORP
MWV
$3.02M 0.03%
64,000
-58,135
-48% -$2.85M
ZSPH
314
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$2.94M 0.03%
56,130
-95,377
-63% -$4.7M
ALSN icon
315
Allison Transmission
ALSN
$9.82B
$2.93M 0.03%
100,000
-468,795
-82% -$14.6M
ORBC
316
DELISTED
ORBCOMM, Inc.
ORBC
$2.87M 0.03%
425,000
-25,000
-6% -$162K
SBNY
317
DELISTED
Signature Bank
SBNY
$2.85M 0.03%
19,451
-159,466
-89% -$22.1M
STOR
318
DELISTED
STORE Capital Corporation
STOR
$2.84M 0.03%
141,253
+6,618
+5% +$143K
CAFD
319
DELISTED
8point3 Energy Partners LP
CAFD
$2.79M 0.03%
+150,000
New +$2.99M
ONCE
320
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$2.77M 0.03%
45,979
+3,361
+8% +$222K
NVCN
321
DELISTED
Neovasc Inc.
NVCN
$2.77M 0.03%
16
+1
+7% +$193K
FLG
322
Flagstar Bank National Association
FLG
$5.82B
$2.72M 0.03%
+49,318
New +$2.6M
RXII
323
CALL
DELISTED
GALENA BIOPHARMA INC COM
RXII
$2.71M 0.03%
1,593,277
– –
SBUX icon
324
CALL
Starbucks
SBUX
$120B
$2.68M 0.03%
50,000
-391,400
-89% -$19.9M
PRTY
325
DELISTED
Party City Holdco Inc.
PRTY
$2.59M 0.03%
+127,713
New +$2.73M
11 12
13
14 15

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q2 2015 Portfolio in Review

As of Q2 2015, Alyeska Investment Group held 656 positions worth $8.84B, up 22% from $7.22B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Alyeska Investment Group deployed $1.69B of net new capital in Q2 2015, opening 169 new positions and adding to 202 existing holdings. Its largest new stake was Infosys: 8,002,538 shares worth $63.4M.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Ciena, an estimated $33.5M trimmed.

  • Alyeska Investment Group's largest Q2 2015 buy was Infosys: 8,002,538 shares worth $63.4M.
  • Alyeska Investment Group added most to Rithm Capital in Q2 2015, an estimated $78.4M increase.
  • Alyeska Investment Group's biggest Q2 2015 reduction was Ciena, cutting an estimated $33.5M.
  • Alyeska Investment Group fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $69.1M.
  • Alyeska Investment Group's ten largest holdings make up 18% of its $8.84B portfolio in Q2 2015.
  • Alyeska Investment Group opened 169 new positions and closed 175 in Q2 2015.
  • Alyeska Investment Group's portfolio value rose 22% quarter-over-quarter to $8.84B.

Based on Alyeska Investment Group's 13F filing for Q2 2015, filed 14 Aug 2015.